Che Xiangming
Impact in
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer-related Molecular Pathways
Papers in
- Oncology 8
- Cancer-related Molecular Pathways 4
- Pancreatic and Hepatic Oncology Research 2
- Co-authors
- Takashi Aikou (16 shared papers)Shoji Natsugoe (10 shared papers)Shuichi Hokita (12 shared papers)Sumiya Ishigami (8 shared papers)Kuniaki Aridome (5 shared papers)Hirohumi Iwashige (4 shared papers)Koki Tokuda (4 shared papers)Akihiro Nakajo (4 shared papers)
In The Last Decade
Che Xiangming
19 papers receiving 961 citations
Peers
Comparison fields: 5 of 71
- Immunology 417
- Oncology 412
- Cancer Research 59
- Pulmonary and Respiratory Medicine 124
- Pathology and Forensic Medicine 68
Countries citing papers authored by Che Xiangming
This map shows the geographic impact of Che Xiangming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Che Xiangming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Che Xiangming more than expected).
Fields of papers citing papers by Che Xiangming
This network shows the impact of papers produced by Che Xiangming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Che Xiangming. The network helps show where Che Xiangming may publish in the future.
Co-authors
The 25 scholars most cited alongside Che Xiangming, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 460 | |
| 2 | 2000 | 117 | |
| 3 | Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus. | 2002 | 77 |
| 4 | Expression of p21WAF1/Cip1 in the p53-dependent pathway is related to prognosis in patients with advanced esophageal carcinoma. | 1999 | 51 |
| 5 | Preserved Smad4 expression in the transforming growth factor beta signaling pathway is a favorable prognostic factor in patients with advanced gastric cancer. | 2001 | 43 |
| 6 | 1999 | 36 | |
| 7 | 2000 | 36 | |
| 8 | 1998 | 32 | |
| 9 | 2000 | 29 | |
| 10 | 2000 | 28 | |
| 11 | Intranodal antitumor immunocyte infiltration in node-negative gastric cancers. | 2000 | 15 |
| 12 | 1998 | 15 | |
| 13 | 1998 | 14 | |
| 14 | 1997 | 13 | |
| 15 | 2015 | 12 | |
| 16 | 2009 | 5 | |
| 17 | [Effects of β-elemene on proliferation and apoptosis of SGC7901 gastric cancer cells in vitro and the underlying mechanisms]. | 2015 | 4 |
| 18 | 2000 | 3 | |
| 19 | 1998 | 1 |
About Che Xiangming
Che Xiangming is a scholar working on Oncology, Pathology and Forensic Medicine, Immunology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 19 papers that have together received 991 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (4 papers), Immune Cell Function and Interaction (4 papers), RNA modifications and cancer (3 papers), Wnt/β-catenin signaling in development and cancer (3 papers), Cancer-related gene regulation (3 papers), Kruppel-like factors research (2 papers), TGF-β signaling in diseases (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Immunology (417 citations), Oncology (412 citations), Cancer Research (59 citations), Pulmonary and Respiratory Medicine (124 citations) and Pathology and Forensic Medicine (68 citations). Che Xiangming has collaborated with scholars based in Japan and China. Frequent co-authors include Takashi Aikou, Shoji Natsugoe, Shuichi Hokita, Sumiya Ishigami, Kuniaki Aridome, Hirohumi Iwashige, Koki Tokuda, Akihiro Nakajo, Sonshin Takao and Masamichi Baba. Their work appears in journals such as Cancer, Cancer Letters, Annals of Surgical Oncology, Oncology and Gastric Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.